A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience

Ryan H. Engel, Jennifer A. Brown, Jamie H. Von Roenn, Ruth M. O'Regan, Raymond Bergan, Sunil Badve, Alfred Rademaker, William J. Gradishar

Research output: Contribution to journalArticle

53 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience'. Together they form a unique fingerprint.

Medicine & Life Sciences